Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

MUCOSAL DRYNESS side effect

What is MUCOSAL DRYNESS ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with MUCOSAL DRYNESS

ENABLEX  FLUNISOLIDE  INFLIXIMAB  NAPROXEN  XELODA  


MUCOSAL DRYNESS : Flunisolide Side Effects Report #5512620-1
Pharmacist from UNITED STATES reported FLUNISOLIDE problem on Nov 08, 2007. Male patient, 40 years of age, weighting 202.6 lb, was treated with FLUNISOLIDE. After drug was administered, patient experienced the following problems/side effects: mucosal dryness, . FLUNISOLIDE dosage: unknown. Patient recovered.

MUCOSAL DRYNESS : Infliximab Side Effects Report #5515861-2
INFLIXIMAB problem was reported by a Physician from BELGIUM on Nov 04, 2007. Female patient was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: mucosal dryness, parosmia, pruritus, . INFLIXIMAB dosage: unknown. Patient recovered.

MUCOSAL DRYNESS : Naproxen Side Effects Report #5664659-3
Physician from SPAIN reported NAPROXEN problem on Feb 28, 2008. Female patient, 61 years of age, was diagnosed with diabetes mellitus and was treated with NAPROXEN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, metabolic acidosis, mucosal dryness, renal failure acute, somnolence, vomiting, . NAPROXEN dosage: unknown. During the same period patient was treated with METFORMIN, GLIBENCLAMIDE, CAPTOPRIL, LEVOTHYROXINE, DICLOFENAC, ROFECOXIB. Patient was hospitalized. Patient recovered.

MUCOSAL DRYNESS : Xeloda Side Effects Report #5546781-5
XELODA problem was reported by a Health Professional from ITALY on Nov 29, 2007. Male patient, 66 years of age, was diagnosed with gastrointestinal neoplasm and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: colon gangrene, diarrhoea, mucosal dryness, . XELODA dosage: unknown. During the same period patient was treated with FARMORUBICINA, CISPLATIN. Patient recovered.

MUCOSAL DRYNESS : Xeloda Side Effects Report #5573081-X
Health Professional from ITALY reported XELODA problem on Dec 19, 2007. Male patient, 66 years of age, was diagnosed with gastrointestinal neoplasm and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: colon gangrene, diarrhoea, mucosal dryness, . XELODA dosage: unknown. During the same period patient was treated with FARMORUBICINA, CISPLATIN. Patient recovered.

MUCOSAL DRYNESS : Enablex Side Effects Report #5477117-6
ENABLEX problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Male patient, 76 years of age, was diagnosed with hypertonic bladder and was treated with ENABLEX. After drug was administered, patient experienced the following problems/side effects: disorientation, judgement impaired, mucosal dryness, . ENABLEX dosage: 7.5 MG, QD, ORAL. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about MUCOSAL DRYNESS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about MUCOSAL DRYNESS